Literature DB >> 9493147

Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature.

P Caramaschi1, M M Riccetti, A F Pasini, T Savarin, D Biasi, G Todeschini.   

Abstract

We describe three female patients affected by both systemic lupus erythematosus and thrombotic thrombocytopenic purpura, one with a fatal outcome. The literature about this disease association is reviewed.

Entities:  

Mesh：

Year:  1998        PMID： 9493147     DOI： 10.1191/096120398678919705

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


  5 in total

1.  Intravenous cyclophosphamide therapy in a case with refractory thrombotic microangiopathic hemolytic anemia and SLE.

Authors:  Jun Akaogi; Noriko Akasaka; Hidehiro Yamada; Nobuaki Hama; Minoru Satoh; Cody Nichols; Shoichi Ozaki
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

2.  Acute epiglottitis as the initial presentation of pediatric Systemic Lupus Erythematosus.

Authors:  Sirirat Charuvanij; Kristin M Houghton
Journal:  Pediatr Rheumatol Online J       Date:  2009-10-31       Impact factor: 3.054

3.  Thrombotic thrombocytopenic purpura associated with cerebral SLE.

Authors:  M McHenry; G Meenagh; G D Wright
Journal:  Ulster Med J       Date:  2003-05

4.  Pernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the Literature.

Authors:  Farhanah Yousaf; Bruce Spinowitz; Chaim Charytan; Marilyn Galler
Journal:  Case Rep Med       Date:  2017-02-06

5.  Cyclophosphamide-rescued plasmapheresis-unresponsive secondary thrombotic thrombocytopenic purpura caused by Sjögren's syndrome.

Authors:  Ting-Yun Lin; Chun-Cheng Chang; Chun-Chao Chang; Jui-Yu Yuan; Hsi-Hsien Chen
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.